| Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials JY Wu, YW Tsai, WH Hsu, TH Liu, PY Huang, MH Chuang, MY Liu, ... Critical Care 27 (1), 274, 2023 | 32 | 2023 |
| Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors WH Hsu, YW Tsai, JY Wu, TH Liu, CC Lai Journal of Infection 86 (4), e107-e110, 2023 | 15 | 2023 |
| Efficacy of nirmatrelvir and ritonavir for post‐acute COVID‐19 sequelae beyond 3 months of SARS‐CoV‐2 infection MH Chuang, JY Wu, TH Liu, WH Hsu, YW Tsai, PY Huang, CC Lai Journal of Medical Virology 95 (4), e28750, 2023 | 14 | 2023 |
| Clinical effectiveness of oral antiviral agents in older patients with COVID‐19 based on real‐world data YW Tsai, JY Wu, TH Liu, MH Chuang, WH Hsu, PY Huang, CC Lai, ... Journal of medical virology 95 (6), e28869, 2023 | 12 | 2023 |
| Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19 JY Wu, MY Liu, TH Liu, MH Chuang, WH Hsu, PY Huang, YW Tsai, ... Journal of Medical Virology 95 (6), e28866, 2023 | 12 | 2023 |
| Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data TH Liu, PY Huang, JY Wu, MH Chuang, WH Hsu, YW Tsai, CC Chang, ... Journal of Medical Virology 95 (5), e28801, 2023 | 9 | 2023 |
| Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19 JY Wu, MY Liu, TH Liu, MH Chuang, WH Hsu, PY Huang, YW Tsai, ... International Journal of Antimicrobial Agents 62 (6), 106984, 2023 | 8 | 2023 |
| Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study TH Liu, MH Chuang, JY Wu, PY Huang, YW Tsai, WH Hsu, CC Lai Journal of Medical Virology 95 (8), e28992, 2023 | 6 | 2023 |
| Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis WH Hsu, BW Shiau, TH Liu, JY Wu, YW Tsai, PY Huang, MH Chuang, ... Expert Review of Anti-infective Therapy 21 (10), 1143-1151, 2023 | 5 | 2023 |
| The effect of molnupiravir on post-acute outcome of COVID-19 survivors WH Hsu, BW Shiau, YW Tsai, JY Wu, TH Liu, MH Chuang, CC Lai The Journal of Infection, 2023 | 4 | 2023 |
| Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases TH Liu, JY Wu, PY Huang, WH Hsu, MH Chuang, YW Tsai, CC Lai, ... Expert Review of Anti-infective Therapy 22 (1-3), 121-128, 2024 | 3 | 2024 |
| Post-COVID-19 condition risk in patients with intellectual and developmental disabilities: a retrospective cohort study involving 36,308 patients TH Liu, PY Huang, JY Wu, MH Chuang, WH Hsu, YW Tsai, PH Kao, ... BMC medicine 21 (1), 505, 2023 | 3 | 2023 |
| Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection JY Wu, MY Liu, WH Hsu, YW Tsai, TH Liu, PY Huang, MH Chuang, ... European Journal of Nutrition 63 (2), 613-622, 2024 | 2 | 2024 |
| The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19 JY Wu, MY Liu, MC Lee, KC Hung, WH Hsu, YW Tsai, TH Liu, PY Huang, ... Expert Review of Anti-infective Therapy, 1-10, 2024 | 2 | 2024 |
| Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza TH Liu, PY Huang, JY Wu, MH Chuang, WH Hsu, YW Tsai, CC Lai BMC medicine 21 (1), 1-10, 2023 | 2 | 2023 |
| Nutritional deficiency anemia and post‐acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: A six‐month retrospective cohort analysis of … JY Wu, MY Liu, KC Hung, WH Hsu, YW Tsai, TH Liu, PY Huang, ... Journal of Medical Virology 95 (11), e29246, 2023 | 2 | 2023 |
| The association between zinc deficiency, and clinical outcomes of COVID-19 JY Wu, WH Hsu, YW Tsai, TH Liu, PY Huang, MH Chuang, SE Chin, ... Journal of Infection 87 (4), e63-e67, 2023 | 2 | 2023 |
| Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients SF Tey, YW Tsai, JY Wu, TH Liu, MH Chuang, WH Hsu, PY Huang, ... Frontiers in Public Health 12, 1337646, 2024 | 1 | 2024 |
| The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study CC Yang, YW Tsai, SH Wang, JY Wu, TH Liu, WH Hsu, PY Huang, ... Frontiers in Pharmacology 15, 1321155, 2024 | 1 | 2024 |
| Risk of cytomegalovirus diseases among coronavirus disease survivors: A retrospective cohort study B Zhang, YW Tsai, JY Wu, TH Liu, MH Chuang, WH Hsu, PY Huang, ... Journal of Medical Virology 95 (9), e29096, 2023 | 1 | 2023 |
